Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-04-20

Clinical Trial Update: The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia

View source ↗

Summary

This clinical trial update notes that the study examining macrophage function in spleen tissue from patients with immune thrombocytopenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Status: WITHDRAWN